Displaying post 1 to 9 of 9
The fight over an experimental cancer therapy gets ugly.
The FDA's decision to delay approval of Provenge, an experimental therapy for advanced prostate cancer, has incensed patients and advocacy groups, who have launched a sophisticated lobbying effort
calling for the drug's approval and questioning the motives of critics. Of course, investors in
Dendreon, the creators of Provenge, have a strong financial interest in seeing Provenge approved.
The New Yorker covers the complicated issues surrounding patient access to experimental therapies
in this story.
posted to MetaFilter by myeviltwin
at 7:48 AM on July 6, 2007
(28 comments)
Am I wrong to thing that
this is way out of line?
posted to MetaTalk by myeviltwin
at 9:25 AM on April 7, 2007
(288 comments)
Is there a way to roll over U.S. government bonds into an IRA tax-free?
posted to Ask Metafilter by myeviltwin
at 6:21 AM on November 2, 2006
(3 comments)
Which Firefox extensions should I install?
posted to Ask Metafilter by myeviltwin
at 9:28 AM on October 24, 2006
(43 comments)
Music nerds love nothing better than lists, and the end of the year is an excellent excuse to make one. Here are
Rolling Stone's,
Pitchfork's, and
Boomkat's lists of the best albums of 2004. What albums did you enjoy in 2004?
posted to MetaFilter by myeviltwin
at 1:31 PM on January 1, 2005
(120 comments)
Terror warnings boost Bush's approval ratings.
Cornell sociologist Robb Willard has used a time-series regression analysis to show that a terror alert by the US government predicts an increase in Bush's approval ratings, even on topics unrelated to security.
It's often been
claimed that the Bush administration manipulates terror alerts for political gain — does this finding make those claims more plausible?
posted to MetaFilter by myeviltwin
at 10:19 PM on October 7, 2004
(9 comments)